Dr. Coors Treats First Patient in DAYBREAK Clinical Trial of Intravitreal Tarcocimab Tedromer and Tabirafusp Tedromer for Wet AMD
Texas Retina’s Lori E. Coors, MD, recently enrolled and treated the first patient in the Phase III DAYBREAK trial evaluating an intravitreal tarcocimab tedromer and tabirafusp tedromer compared with intravitreal aflibercept in
read more
Dr. Abbey Doses First Patient in Phase III LUGANO Clinical Trial of Duravyu for Wet AMD
Texas Retina Associates Director of Clinical Research for Dallas Ashkan Abbey, MD, recently dosed the first patient in the Phase III LUGANO clinical trial of Duravyu (formerly EYP-1901) for the treatment of
read more
Dr. Coors and Dr. Christopher Fuller Served as Invited Faculty for Retina LIVE! Surgical Case Series Event
Texas Retina Associates’ Lori E. Coors, MD, and Christopher G. Fuller, MD, joined speakers from Bascom Palmer Eye Institute, Stanford University’s Byers Eye Institute, and Duke University Eye Center as part of
read more
New Clinical Trials Enrolling in Plano
At Texas Retina Associates, we remain committed to examining new options that are ethical, based on a solid science platform and provide minimal risks to our patients. Our Plano research team is
read more
North Dallas Office Moving to a New Suite
To better serve our patients, Texas Retina Associates will be moving our Dallas North office to a much larger suite within the same building. Opening Monday, July 6, 2020, the new Dallas
read more
Texas Retina Associates Held 18th Annual Vitreoretinal Disease Update for Optometrists
On May 5, 2019, 180 optometrists attended Texas Retina Associates’ Vitreoretinal Disease Update 2019, an annual continuing education event held this year at the Fogelson Forum at Texas Health Presbyterian Hospital Dallas.
read more
Getting to Know Lori E. Coors, MD
With 13 years of experience, board-certified retina specialist Lori E. Coors, MD, has been a part of Texas Retina Associates since 2005 and sees patients in our Dallas North, Plano and Sherman offices.
read more
